Brief: MyMD Pharmaceuticals Provides Dosing Update On Phase 2 Multi-Center Clinical Trial Of MYMD-1
20/09/2022 14:28
Sept 20 (Reuters) - MyMD Pharmaceuticals Inc MYMD.O :
* MYMD PHARMACEUTICALS® PROVIDES DOSING UPDATE ON PHASE 2
MULTI-CENTER CLINICAL TRIAL OF MYMD-1® AS A THERAPY FOR DELAYING
AGING AND EXTENDING HEALTHY LIFESPAN
* MYMD PHARMACEUTICALS® PROVIDES DOSING UPDATE ON PHASE 2
MULTI-CENTER CLINICAL TRIAL OF MYMD-1® AS A THERAPY FOR DELAYING
AGING AND EXTENDING HEALTHY LIFESPAN
* MYMD PHARMACEUTICALS INC - EFFICACY DATA ANTICIPATED IN Q4
OF
2022
Source text for Eikon: ID:nBw3JLG2ma
Further company coverage: MYMD.O
((Reuters.Briefs@thomsonreuters.com;))